Lung ablation: Best practice/results/response assessment/role alongside other ablative therapies

Dupuy, 2001, Image-guided radiofrequency tumour ablation: challenges and opportunities—part II, J Vasc Interv Radiol, 12, 1135, 10.1016/S1051-0443(07)61670-4 Nishida, 2002, Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients, J Am Coll Surg, 195, 426, 10.1016/S1072-7515(02)01281-4 de Baere, 2006, Mid-term local efficacy and survival after radiofrequency ablation of lung tumours with a minimum follow-up of 1 year: prospective evaluation, Radiology, 240, 587, 10.1148/radiol.2402050807 Wolf, 2008, Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients, Radiology, 247, 871, 10.1148/radiol.2473070996 Vogl, 2011, Microwave ablation therapy: clinical utility in treatment of pulmonary metastases, Radiology, 261, 643, 10.1148/radiol.11101643 Suh, 2003, Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation—preliminary results, Radiology, 229, 821, 10.1148/radiol.2293021756 Hamada, 2012, Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates, Jpn J Radiol, 30, 567, 10.1007/s11604-012-0089-0 Abtin, 2012, Radiofrequency ablation of lung tumours: imaging features of the postablation zone, RadioGraphics, 32, 947, 10.1148/rg.324105181 Hess, 2011, Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance, Radiology, 258, 635, 10.1148/radiol.10100771 Okunieff, 2006, Stereotactic body radiation therapy (SBRT) for lung metastases, Acta Oncol, 45, 808, 10.1080/02841860600908954 de Baere, 2015, Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases, Ann Oncol, 26, 987, 10.1093/annonc/mdv037 Lencioni, 2008, Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study), Lancet Oncol, 9, 621, 10.1016/S1470-2045(08)70155-4 Pastorino, 1997, Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases, J Thorac Cardiovasc Surg, 113, 37, 10.1016/S0022-5223(97)70397-0 Treasure, 2007, Pulmonary metastasectomy: a common practice based on weak evidence, Ann R Coll Surg Engl, 89, 744, 10.1308/003588407X232198 Ahmed, 2004, Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumour model, Radiology, 230, 761, 10.1148/radiol.2303021801 Goldberg, 1995, Radiofrequency tissue ablation in the rabbit lung: efficacy and complications, Acad Radiol, 2, 776, 10.1016/S1076-6332(05)80852-9 Miao, 2001, Radiofrequency ablation for eradication of pulmonary tumour in rabbits, J Surg Res, 99, 265, 10.1006/jsre.2001.6208 Jaskolka, 2010, Pathologic assessment of radiofrequency ablation of pulmonary metastases, J Vasc Interv Radiol, 21, 1689, 10.1016/j.jvir.2010.06.023 Zhu, 2008, A systematic review of radiofrequency ablation for lung tumours, Ann Surg Oncol, 15, 1765, 10.1245/s10434-008-9848-7 Gillams, 2008, Radiofrequency ablation of lung metastases: factors influencing success, Eur Radiol, 18, 672, 10.1007/s00330-007-0811-y Hiraki, 2006, Risk factors for local progression after percutaneous radiofrequency ablation of lung tumours: evaluation based on a preliminary review of 342 tumours, Cancer, 107, 2873, 10.1002/cncr.22333 Okuma, 2010, Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumours: 9-year experience in a single institution, Cardiovasc Intervent Radiol, 33, 787, 10.1007/s00270-009-9770-9 Anderson, 2009, Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumours, Cardiovasc Intervent Radiol, 32, 478, 10.1007/s00270-008-9482-6 Giraud, 2000, Evaluation of microscopic tumour extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning, Int J Radiat Oncol Biol Phys, 48, 1015, 10.1016/S0360-3016(00)00750-1 Shiono, 2005, Predictive factors for local recurrence of resected colorectal lung metastases, Ann Thorac Surg, 80, 1040, 10.1016/j.athoracsur.2004.12.033 Planche, 2013, In vivo evaluation of lung microwave ablation in a porcine tumour mimic model, Cardiovasc Intervent Radiol, 36, 221, 10.1007/s00270-012-0399-8 Hiraki, 2006, Percutaneous radiofrequency ablation combined with previous bronchial arterial chemoembolization and followed by radiation therapy for pulmonary metastasis from hepatocellular carcinoma, J Vasc Interv Radiol, 17, 1189, 10.1097/01.RVI.0000228370.09886.66 de Baere, 2011, Radiofrequency ablation of lung metastases close to large vessels during vascular occlusion: preliminary experience, J Vasc Interv Radiol, 22, 749, 10.1016/j.jvir.2011.02.028 Brace, 2009, Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?, Curr Probl Diagn Radiol, 38, 135, 10.1067/j.cpradiol.2007.10.001 Brace, 2009, Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model, Radiology, 25, 705, 10.1148/radiol.2513081564 Crocetti, 2010, Thermal ablation of lung tissue: in vivo experimental comparison of microwave and radiofrequency, Cardiovasc Intervent Radiol, 33, 818, 10.1007/s00270-010-9869-z Ierardi, 2015, A new system of microwave ablation at 2450 MHz: preliminary experience, Updates Surg, 67, 39, 10.1007/s13304-015-0288-1 de Baere, 2015, Evaluating cryoablation of metastatic lung tumours in patients – safety and efficacy: the ECLIPSE trial — interim analysis at 1-year, J Thorac Oncol, 10, 1468, 10.1097/JTO.0000000000000632 Davalos, 2005, Tissue ablation with irreversible electroporation, Ann Biomed Eng, 33, 223, 10.1007/s10439-005-8981-8 Deodhar, 2011, Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization, AJR Am J Roentgenol, 196, W330, 10.2214/AJR.10.4490 Dupuy, 2011, Irreversible electroporation in a swine lung model, Cardiovasc Intervent Radiol, 34, 391, 10.1007/s00270-010-0091-9 Ricke, 2015, Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial, Cardiovasc Intervent Radiol, 38, 401, 10.1007/s00270-014-1049-0 Landreneau, 2000, Therapeutic video-assisted thoracoscopic surgical resection of colorectal pulmonary metastases, Eur J Cardiothorac Surg, 18, 671, 10.1016/S1010-7940(00)00580-7 Chua, 2010, Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients, Ann Oncol, 21, 2017, 10.1093/annonc/mdq098 Gillams, 2012, Survival after radiofrequency ablation in 122 patients with inoperable colorectal lung metastases, Cardiovasc Intervent Radiol Pastorino, 1998, A new staging proposal for pulmonary metastases. The results of analysis of 5206 cases of resected pulmonary metastases, Chest Surg Clin N Am, 8, 197 Gonzalez, 2013, Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis, Ann Surg Oncol, 20, 572, 10.1245/s10434-012-2726-3 Iida, 2013, Prognostic factors after pulmonary metastasectomy for colorectal cancer and rationale for determining surgical indications: a retrospective analysis, Ann Surg, 257, 1059, 10.1097/SLA.0b013e31826eda3b Schneider, 2011, The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms — results of an ablate and resect study, Eur J Cardiothorac Surg, 39, 968, 10.1016/j.ejcts.2010.08.055 Cazzato, 2015, Cone-beam computed tomography (CBCT) versus CT in lung ablation procedure: which is faster?, Cardiovasc Intervent Radiol, 38, 1231, 10.1007/s00270-015-1078-3 Simon, 2007, Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients, Radiology, 243, 268, 10.1148/radiol.2431060088 Kodama, 2012, Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention, Cardiovasc Intervent Radiol, 35, 563, 10.1007/s00270-011-0220-0 Simon, 2012, Charlson comorbidity index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation, Eur J Radiol, 81, 4167, 10.1016/j.ejrad.2012.06.007 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Tominaga, 2005, Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study, J Vasc Interv Radiol, 16, 1719, 10.1097/01.RVI.0000182507.37324.3E Hinshaw, 2010, Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol, Cardiovasc Intervent Radiol, 33, 1180, 10.1007/s00270-010-9868-0 Lee, 2004, Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report, Radiology, 230, 125, 10.1148/radiol.2301020934 Jin, 2004, Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT, AJR Am J Roentgenol, 183, 1013, 10.2214/ajr.183.4.1831013 Ito, 2012, Computed tomographic appearance of lung tumours treated with percutaneous cryoablation, J Vasc Interv Radiol, 23, 1043, 10.1016/j.jvir.2012.04.033 Palussiere, 2011, Lung tumours treated with percutaneous radiofrequency ablation: computed tomography imaging follow-up, Cardiovasc Intervent Radiol, 34, 989, 10.1007/s00270-010-0048-z Bojarski, 2005, CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumours, AJR Am J Roentgenol, 185, 466, 10.2214/ajr.185.2.01850466 Beland, 2010, Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation, Radiology, 254, 301, 10.1148/radiol.00000090174 Suzawa, 2013, Detection of local tumour progression by 18F-FDG PET/CT following lung radiofrequency ablation: PET versus CT, Clin Nucl Med, 38, e166, 10.1097/RLU.0b013e31828166f6 Deandreis, 2011, Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation, Radiology, 258, 270, 10.1148/radiol.10092440 Zemlyak, 2010, Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer, J Am Coll Surg, 211, 68, 10.1016/j.jamcollsurg.2010.03.020 Kim, 2012, Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer, Eur J Radiol, 81, 395, 10.1016/j.ejrad.2010.12.091 Dominguez-Ventura, 2006, Lymphadenectomy in metastasectomy, Thorac Surg Clin, 16, 139, 10.1016/j.thorsurg.2005.12.001 Inoue, 2004, Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma, Ann Thorac Surg, 78, 238, 10.1016/j.athoracsur.2004.02.017 Pfannschmidt, 2010, Reported outcome factors for pulmonary resection in metastatic colorectal cancer, J Thorac Oncol, 5, S172, 10.1097/JTO.0b013e3181dca330 Fode, 2015, Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases, Radiother Oncol, 114, 155, 10.1016/j.radonc.2014.12.003 Trumm, 2014, CT fluoroscopy-guided percutaneous fiducial marker placement for CyberKnife stereotactic radiosurgery: technical results and complications in 222 consecutive procedures, J Vasc Interv Radiol, 25, 760, 10.1016/j.jvir.2014.01.004 Chang, 2015, Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials, Lancet Oncol, 16, 630, 10.1016/S1470-2045(15)70168-3 Chang, 2015, Surgery versus SABR for resectable non-small-cell lung cancer—authors' reply, Lancet Oncol, 16, e374, 10.1016/S1470-2045(15)00154-0 Maruyama, 2014, A feasibility trial of postoperative adjuvant chemotherapy with S-1, an oral fluoropyrimidine, for elderly patients with non-small cell lung cancer: a report of the Lung Oncology Group in Kyushu (LOGIK) protocol 0901, Int J Clin Oncol, 19, 57, 10.1007/s10147-013-0516-y Wei, 2015, Microwave ablation plus chemotherapy improved progression-free survival of advanced non-small cell lung cancer compared to chemotherapy alone, Med Oncol, 32, 464, 10.1007/s12032-014-0464-z Ni, 2016, Medicine, 95, e3998, 10.1097/MD.0000000000003998 Yoo, 2011, Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?, AJR Am J Roentgenol, 197, 334, 10.2214/AJR.10.6108